In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B

J K Chia1, E J McManus

  • 1Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20892.

Insights

Amphotericin B can cause fever by stimulating tumor necrosis factor alpha (TNF-alpha). This study found a recalled Amphotericin B lot induced more TNF-alpha in vitro, correlating with patient reactions and pyrogen tests.

Area of Science:

  • Immunology
  • Pharmacology
  • Toxicology

Background:

  • Amphotericin B administration is linked to febrile toxicity.
  • Tumor necrosis factor alpha (TNF-alpha) is an inflammatory mediator implicated in Amphotericin B-induced fever.
  • Variations in drug lots may influence patient reactions.

Purpose of the Study:

  • To compare the in vitro TNF-alpha-inducing activity of two Amphotericin B lots.
  • To determine if in vitro TNF-alpha induction correlates with clinical febrile reactions.
  • To evaluate the utility of an in vitro assay for predicting pyrogenicity.

Main Methods:

  • In vitro testing of Amphotericin B preparations for TNF-alpha induction by macrophages.
  • Comparison of TNF-alpha levels between a recalled lot and a non-recalled lot.
  • Correlation analysis with rabbit pyrogen testing results.

Main Results:

  • The recalled Amphotericin B lot demonstrated significantly higher in vitro TNF-alpha induction compared to the non-recalled lot.
  • In vitro TNF-alpha induction levels correlated with results from rabbit pyrogen testing.
  • The findings suggest a link between TNF-alpha production and Amphotericin B pyrogenicity.

Conclusions:

  • In vitro TNF-alpha induction assay can identify Amphotericin B lots with higher pyrogenic potential.
  • This assay may serve as a valuable screening tool to select less pyrogenic drug preparations.
  • Reducing pyrogenic reactions can improve patient tolerance to Amphotericin B therapy.

Related Concept Videos